Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Pocius, Kristina
DOB: 20-JAN-1944 (Age: 82)
Gender: male
Address:
99218 Nagys Ridge
93234 West Marijaside (Lithuania)
ID: 5121-608381-9 (ECI)
Report
Date: 14-MAY-2022
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Dr. Tomas Bakas
182 Savanorių pr.
LT-91200 Klaipėda (Lithuania)
Specimen
Collected: 14-MAY-2022

Chemistry

Test 14-MAY-2022 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.5 4.8 - 5.9 %
Glucose [Mass/volume] in Blood 64.7 L 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 8.9 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.8 0.6 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.0 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 140.0 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.4 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 108.7 H 98 - 107 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 26.6 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 162.6 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 148.2 0 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 102.5 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 30.4 L 40 - 60 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 16.3 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mild hypoglycemia, slightly elevated chloride and LDL cholesterol, and low HDL cholesterol. Other parameters, including renal function and HbA1c, are within normal limits. Lipid profile suggests increased cardiovascular risk. Recommend monitoring glucose levels, optimizing lipid management, and considering cardiovascular risk reduction strategies. No evidence of renal impairment or significant proteinuria.